The Bitcoin price has slipped 2% over the last 24 hours to trade at $101,647 as of 4.05 a.m. EST with the daily trading volume [...]The Bitcoin price has slipped 2% over the last 24 hours to trade at $101,647 as of 4.05 a.m. EST with the daily trading volume [...]

Strategy Buys $45 Million In Bitcoin, Plans Euro-Denominated STRE Offering To Fund More

Michael Saylor’s Strategy has bought $45 million Bitcoin and plans a euro-denominated preferred stock offering (STRE) to fund more BTC buys.

The company disclosed in a Securities and Exchange Commission (SEC) filing that it purchased 397 Bitcoin last week at an average price of $114,771, bringing its total holdings to 641,205 BTC bought for $47.49 billion and currently worth about $66.7 billion.

In a separate press release, Strategy said it plans to sell 3.5 million euro-denominated perpetual preferred shares, or STREs, to fund future Bitcoin purchases and other corporate needs. The offering remains subject to market conditions, it said

Each STRE share carries a €100 face value and a 10% annual dividend, payable quarterly from late 2025 if declared. Missed payments will accrue interest and rise by one percentage point annually until paid.

If there is a case where Strategy misses a dividend payment, the amount that was meant to be paid will earn extra interest that compounds each quarter, the company said. In such a scenario, the dividend rate will rise by 1% per year until Strategy catches up. 

Strategy also said that if it is unable to pay any dividends to STRE share holders, it has to issue a “notice of deferral.” The company will then try to raise funds to pay investors their dividends within 60 days. To cover these missed payments, Strategy said it may look to sell other classes of its stock.

Strategy can also choose to buy back or redeem all STRE shares in cash under two conditions. The first condition is that fewer than 25% of the originally issued shares remain outstanding, while the second is if certain tax-related events occur. 

Strategy Builds On Existing Preferred Stock Offerings

The STRE offering is the latest addition to Strategy’s range of preferred stock offerings, which include STRF, STRK, STRD, and STRC.

STRF offers investors cumulative dividends at a fixed rate of 10% per annum on a stated amount regardless of whether dividends are declared, while STRK offers a fixed dividend rate of 8% per annum and includes a conversion feature. 

Meanwhile, STRD has a 10% annual dividend rate. Lastly, STRC gives investors dividends that adjust monthly and that are paid in cash when declared by the company.

Strategy has already started using some of the proceeds from those stock offerings to purchase Bitcoin.

Strategy started purchasing Bitcoin back in 2020, and is the pioneer behind the digital asset treasury (DAT) model. Numerous companies have followed Strategy’s lead, and some have applied the model to cryptos including Ethereum (ETH), Toncoin (TON),  and Solana (SOL). 

Its buying activity has slowed recently. In October, it bought 778 BTC, one of the smallest monthly acquisitions in recent years. In September, it bought 3,526 BTC.

Strategy’s Share Price Plunges

Strategy’s stock has dropped more than 10% this week, and over 28% in the past month.

MSTR price (Source: Google Finance)

Market Opportunity
Moonveil Logo
Moonveil Price(MORE)
$0.00223
$0.00223$0.00223
-4.25%
USD
Moonveil (MORE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23